Skip to content

Use of Kushmanda Taila Uttar Basti in the management of Mutraghata (BPH).

Effect of Kushmanda Taila Uttar Basti in the management of Mutraghata w.s.r. to BPH. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074700
Enrollment
30
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N400- Benign prostatic hyperplasia without lower urinary tract symptoms

Interventions

None listed

Sponsors

Dr Mohit Bhati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patients of Grade 1 and Grade 2 BPH. Patients aged in between 40 and 70 years.

Exclusion criteria

Exclusion criteria: Patients not having normal PSA value. Patients suffering from acute retention of urine,severe UTI, urethral stricture and bladder and ureteric calculi. Patients having other systemic diseases. Subjects under medications.

Design outcomes

Primary

MeasureTime frame
Reduce the size of prostate.Timepoint: 21 days

Secondary

MeasureTime frame
Relieve in urine obstruction.Timepoint: After analysing all the parameters the result will be assessed on the basis of symptomatic relief and improvement. Partially improvement after 7 days- patients get 40-60 percent relief from sign and symptoms. Improvement after 14 days- patient get 60-80 percent relief from sign and symptoms. Cured after 21 days- Patient get 80-100 percent relief from sign and symptoms.

Countries

India

Contacts

Public ContactDr Ranjit Singh Manhas

Kunwar Shekhar Vijendra Ayurved Medical College and Research Center

ranjit198330@gmail.com9461940996

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026